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Myonectin serum concentration 
changes after short-term physical 
activity among young, healthy people
ABSTRACT
Background: Myonectin is a myokine secreted by skeletal muscles in response to physical activity (PhA) 
in rodents. It was shown that myonectin may be positively associated with insulin resistance parameters. 
The aim of the study was to evaluate changes in the concentration of myonectin after short-term PhA.
Methods: A total of 29 young, healthy volunteers, were included in the study. Each participant completed 
a life-style questionnaire, underwent a physical examination with anthropometric measurement followed 
by a treadmill test according to theBruce protocol. Blood samples were collected before and after PhA. 
An ELISA Assay was used to investigate the myonectin serum level. 
Results: The myonectin serum level did not change significantly after PhA (0.62[0.14-2.9] vs. 1.08[0.15-2.44] 
ng/ml; p=0.84). Before PhA the myonectin serum level differed significantly between men and women 
(respectively: 3.92[2.24-5.30] vs. 0.56[0.15-1.75] ng/ml; p=0.02). Before PhA it had a positive association 
with weight, BMI, serum creatinine and uremic acid (p < 0.05). The change in the level of myonectin se-
rum after PhA had negative associations with weight, BMI, fasting insulin level and HOMA-IR (p < 0.05). 
Conclusions: Myonectin serum concentration does not change after short-term physical activity among 
young, healthy people. Changes in the myonectin serum level after short-term physical activity may be 
associated with fasting insulin resistance. 
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Introduction
Myonectin (CTRP15/C1QTNF/erythroferrone) is 
a novel myokine secreted by skeletal muscles in re-
sponse to physical activity (PhA) and the rise of glucose 
and free fatty acids (FFA) in rodents [1–2]. Myonectin 
increases the expression of proteins transporting FFA 
through hepatocytes and adipocyte cell membranes, 
causing increasing serum FFA uptake [3]. Toloza et 
al. reported that myonectin level is associated with 
insulin resistance (IR) in non-diabetic adults [4]. Lim 
et al. observed that long-term, regular PhA decreases 
both the myonectin serum level and IR measured by 
the homeostasis model assessment [5]. 
It is known that short-term PhA transiently increases 
serum levels of glucose, FFA and IR6. In this context, it 
may be suspected that myonectin serum level should 
increase efter short-term PhA in humans. Currently, no 
study has yet investigated changes in myonectin serum 
level after short-term PhA in human adults.
The aim of the study was to evaluate changes in 
the concentration of myonectin after short-term phys-
ical activity.
Materials and Methods
Design
Cross-sectional, single-centre study.
Data Collection
The study group consisted of volunteers, young 
healthy people. All patients were informed about the 
study and signed an informed consent form. The study 
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protocol was approved by the local Ethic Committee 
(Bioethics Committee of Poznan University of Medi-
cal Sciences).
Inclusion and exclusion criteria
All patients who met the following criteria were in-
cluded: age between 18–26, visitworklab in fasting state, 
voluntarily signed a consent form. Exclusion criteria 
were as follows: metabolic syndrome, acute infection, 
mental disorder, congenital disease, unstable chronic 
disease, general exclusion criteria for a treadmill test. 
Clinical and laboratory data
The worklab visit took place in the morning hours 
(8:00–10:00 AM). All participants had been informed not 
to eat, drink or smoke 8 hours prior to attendance. All in-
dividuals completed a questionnaire including details of 
sex, age, smoking status and The International Physical 
Activity Questionnaire (IPAQ) — a validated question-
naire used to assess weekly PhA expressed as a total 
weekly metabolic equivalent of the task (MET) [7]. The 
patients underwent a complete physical examination 
with anthropometric measurements (weight, height, 
waist circumference) and blood pressure check. Blood 
pressure was measured three times by the Korotkoff 
method in the sitting position, after 10 minutes rest, 
using a mercury manometer. Blood pressure was 
additionally measured after 6 minutes of treadmill test. 
Height and weight were measured using the same 
medical scales for all patients. Weight was measured 
to an accuracy of 100 g and height to 0,5 cm. BMI was 
calculated from the following equations: BMI = weight 
/ squared height [kg/m2].
Blood samples were collected in a fasting state 
using the S-Monovette blood collection system. Serum 
glucose, serum insulin, creatinine, uremic acid and lipid 
profile were assessed according to standard laboratory 
protocols. After the first blood sample collection and 
before the treadmill test, participants ate breakfast. 
6 minutes after the treadmill test a second blood sam-
ple was obtained to assess myonectin serum level 
after PhA. To estimate myonectin serum concentration 
Human (CTRP15/Myonectin) ELISA Kit (ElAab, China) 
was used. All steps of the assay were done according 
to the manufacturer’s instructions. Changes in the 
myonectin serum level were defined as the difference 
between myonectin serum level after and before phys-
ical activity. HOMA-IR was calculated on the basis of 
the equation [8]:
HOMA -IR = (Glucose * Insulin)/22.5
Glucose in mmol/l, Insulin in μIU/ml. 
Treadmill tests were performed by a physician 
in accordance with the Bruce protocol on Car-
diotest1612 (Aspel, Zabrzów, Poland) [9]. For inter-
pretation of the treadmill test and counting MET the 
treadmill manufacturer (Aspel, Zabrzów, Poland) 
software was used.
Statistical analysis
Statistical analysis was performed with STATIS-
TICA 12.0 (StatSoft, USA). The normality of variable 
distributions was tested using the Shapiro-Wilk test. 
For descriptive analysis, Wilcoxon test was used to 
compare the results before and after the treadmill 
test;the Mann-Whitney was performed to compare 
men and women. For comparison of binary variables, 
Fisher’s exact test was used. Differences with a p-val-
ue < 0.05 were considered statistically significant.
Results
The study group consisted of 29 participants 
(male = 10; 34.5%), the features of the group are 
presented in Table 1. All participants had myonectin 
serum levels within the assay range (0.05–15 ng/ml). 
To compare myonectin serum levels and other features 
between men and women the Mann-Whitney U test and 
Fisher’s exact test were used. 
Differences between myonectin serum level, heart 
rate, systolic and diastolic blood pressure before and 
after physical activity were presented in Table 2. The 
R Spearman rank correlation test revealed some sig-
nificant associations between myonectin serum level 
(Table 3).
Discussion
In this study, no significant change was observed 
in the myonectin serum level after short-term PhA. 
Myonectin before PhA was also associated with weight, 
BMI, serum creatinine and uremic acid. The groups of 
men and women differed significantly in age, height, 
weight, BMI, HDL-C, serum creatinine, uremic acid and 
myonectin before PhA levels. Myonectin is secreted 
by skeletal muscles. Skeletal muscle mass in young, 
healthy adults is positively correlated with weight, BMI. 
Moreover, serum creatinine and uremic acid levels are 
dependent on muscle mass [10–11]. These associa-
tions may provide a rationale for the observed results.
Myonectin in response to PhA increases the ex-
pression of CD36, fatty acid transport proteins (FATP), 
and fatty acid binding proteins (FABP) in hepatocytes 
and adipocyte, resulting in increasing FFA uptake [2]. 
It is known that myonectin is associated with IR [4–5] 
and circulating FFA induces IR [12]. It is possible that 
myonectin is secondarily upregulated in the IR state 
in order to diminish circulating FFA levels. In a young, 
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Table 1. General characteristics of the study group
Feature [units] median (IQR) / n (%) Female (n = 19)
median (IQR) / n (%)
Male (n = 10)
median (IQR) / n (%)
p-value
Smokers 4 (13.8) 2 (10).5 2 (20.0) 0.43
Age [years] 22 (20–23) 21 (20–22) 23 (22–23) < 0.01
Height [m] 1.72 (16.5–1.76) 1.69 (1.64–1.72) 1.82 (1.76–1.85) < 0.001
Weight [kg] 59 (54–78) 54 (53–59) 80 (78–86) < 0.001
BMI [kg/m2] 21.3 (19.4–24.0) 20.1 (18.5–21.3) 24.0 (23.8–25.7) < 0.001
Fasting Glucose [mmol/] 5.1 (4.8–5.3) 5.1 (4.8–5.3) 5.1 (4.6–5.4) 0.80
Fasting insulin [μIU/ml] 16.1 (12.5–19.1) 16.7 (12.1–18.6) 15.2 (12.8–19.6) 0.79
HOMA-IR 3.7 (2.8–4.3) 3.7 (2.6–4.2) 3.4 (3.0–4.3) 0.98
Total Cholesterol [mmol/l] 4.4 (3.9–5.2) 4.4 (4.2–5.4) 4.0 (3.7–4.6) 0.07
HDL-C [mmol/l] 1.6 (1.4–1.9) 1.7 (1.5–2.1) 1.4 (1.2–1.7) 0.04
LDL-C [mmol/l] 2.3 (2.0–3.0) 2.3 (2.0–3.1) 2.2 (1.8–2.5) 0.35
Triglycerides [mmol/] 0.84 (0.61–1.1) 0.85 (0.63–1.1) 0.70 (0.48–0.98) 0.33
Serum Creatinine [μmol/l] 70.4 (70.3–79.6) 70.7 (61.9–70.7) 88.4 (79.6–97.3) < 0.001
Uremic Acid [μmol/l] 279.6 (243.9–339.0) 243.9 (214.1–279.6) 358.9 (339.0–395.5) < 0.001
METmax during Treadmill Test  
[kcal/kg/h]
11.8 (10.4–14.3) 11.5 (10.4–14.0) 13.9 (11.8–14.8) 0.23
IPAQ Total Weekly MET [kcal/kg/h] 3448 (1794–4730) 3842 (1794–5205) 2669 (1328–3900) 0.11
Myonectin before PhA [ng/ml] 0.67 (0.14–2.9) 0.15 (0.14–1.09) 3.92 (2.24–5.30) 0.02
Myonectin after PhA [ng/ml] 1.08 (0.15–2.44) 0.56 (0.15–1.75) 2.43 (0.78–4.00) 0.09
Change of the Myonectin Serum Level 0.01 ([–0.84] – 0.67) 0.01 ([–0.17] – 0.95) – 0.65 ([–3.38] – 0.67) 0.10
BMI — Body Mass Index, HDL-C — High-Density Lipoprotein Cholesterol, HOMA-IR — Homeostatic Model Assessment Measuring Insulin Resist-
ance, IPAQ — The International Physical Activity Questionnaire, IQR — Interquartile Range, LDL — Low-Density Lipoprotein Cholesterol, MET — 
Metabolic Equivalent of Task, METmax — Maximal MET
Table 2. Wilcoxon test outcomes 
Before Physical Activity median 
(IQR)
After Physical Activity median 
(IQR)
p value
Myonectin [ng/ml] 0.67 (0.14–2.9) 1.08 (0.15–2.44) 0.84
Systolic Blood Pressure [mmHg] 115 (110–124) 120 (112–124) 0.20
Diastolic Blood Pressure [mmHg] 75 (70–80) 72 (70–80) 0.28
Heart Rate [bpm] 82 (78–93) 96 (91–100) < 0.001
healthy population with no presence of metabolic 
syndrome, the release of myonectin might be too low 
and/or slow in comparison with patients with IR to ob-
serve any significant change in myonectin serum level 
in 6 minutes after short-term PhA. 
Interestingly, the change in the myonectin serum 
level after short-term PhA was negatively associated 
with both insulin in fasting state and HOMA-IR. Toloza et 
al. studied 81 non-diabetic adults and assessed the as-
sociation between insulin resistance direct and indirect 
markers and myokines [4]. Fasting myonectin adjusted 
to BMI, age and sex were found to be negativelyasso-
ciated with the Insulin Sensitivity Index (standardized 
beta = -0.235, p = 0.023). The authors did not report 
any significant association with HOMA-IR. Lim et al. 
investigated the effects of 1-h per week of aerobic phys-
ical activity lasting 10-weeks on myonectin and insulin 
resistance in 14 young (22.5 ± 2.7years) and 14 older 
(60.3 ± 5.2 years) women [5]. Before the training 
apositive correlation between HOMA-IR and myonectin 
serum level was found only in older women in fasting 
state at rest (r = 0.35; p < 0.05). After 10-weeks of train-
ing, changes in HOMA-IR and changes in myonectin 
were positively correlated (r = 0.462; p < 0.01) in both 
groups. Both the aforementioned studies demonstrated 
a positive dependence between insulin resistance and 
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Table 3. Associations between study features and myonectin serum level
Feature [units] Myonectin Before Physical 
Activity [ng/ml]
Myonectin After Physical 
Activity [ng/ml]
Change of the Myonectin 
Serum Level [ng/ml]
Rs p-value Rs p-value Rs p-value
Age [years] 0.33 0.08 0.24 0.22 –0.14 0.47
Height [m] 0.30 0.11 0.35 0.07 –0.08 0.68
Weight [kg] 0.38 0.04 0.21 0.29 –0.41 0.03
BMI [kg/m2] 0.40 0.03 0.19 0.31 –0.47 0.01
Fasting Glucose [mmol/] 0.07 0.71 0.13 0.50 –0.03 0.88
Fasting insulin [μIU/ml] 0.09 0.64 –0.25 0.19 –0.38 0.04
HOMA-IR 0.15 0.45 –0.21 0.29 –0.43 0.02
Total Cholesterol [mmol/l] –0.01 0.95 0.19 0.32 0.20 0.30
HDL-C [mmol/l] –0.21 0.28 0.04 0.84 0.21 0.28
LDL-C [mmol/l] 0.13 0.49 0.30 0.11 0.15 0.44
Triglycerides [mmol/] –0.12 0.55 –0.35 0.06 –0.23 0.22
Serum Creatinine [μmol/l] 0.40 0.03 0.32 0.09 –0.32 0.09
Uremic Acid [μmol/l] 0.41 0.03 0.43 0.02 –0.17 0.38
METmax during Treadmill  
Test [kcal/kg/h]
0.16 0.41 0.04 0.84 –0.20 0.30
IPAQ Total Weekly MET  
[kcal/kg/h]
–0.06 0.78 –0.07 0.71 0.01 0.10
BMI — Body Mass Index, HDL-C — High-Density Lipoprotein Cholesterol, HOMA-IR — Homeostatic Model Assessment Measuring Insulin Resist-
ance, IPAQ — The International Physical Activity Questionnaire, IQR — Interquartile Range, LDL — Low-Density Lipoprotein Cholesterol, MET — 
Metabolic Equivalent of Task, METmax — Maximal MET
myonectin. In our study, no such association was found. 
However, the negative association between changes 
in the myonectin serum level after PhA and simultane-
ously no significant change in myonectin serum level 
after PhA is intriguing. The change in myonectin serum 
level is highest among young volunteers with the lowest 
HOMA-IR value in the fasting state. It is possible that in 
those groups an increase of myonectin is more rapid 
than in the group characterized by higher HOMA-IR 
values. However, this possible phenomenon requires 
more detailed studies. 
This study has several limitations. Firstly, we 
included only 29 volunteers in the study. Secondly, 
no additional data such as body composition or 
FFA were collected. Body composition analysis may 
reveal a potential association between myonectin 
serum level and muscle mass. Finally, we have not 
collected blood samples after a longer period of time 
than 6 minutes.
In conclusion, myonectin serum concentration does 
not change after short-term physical activity among 
young, healthy people. Myonectin serum level may 
be associated with muscle mass in a young, healthy 
population. Changes in myonectin serum level after 
short-term physical activity may be associated with 
fasting insulin resistance. 
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